News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Should Pharma Companies Give Up Discovery Research?


9/11/2013 8:27:33 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A little while back, a fellow Forbes contributor, David Shaywitz, tweeted the following provocative statement: “My ? based on Onyx deal and others: should med/large pharmas just give up all pretense of R & early D (a la Andrew Baum), move explicitly 2 S&D.” Shaywitz is not some yahoo attacking the pharma industry’s R&D capabilities. He is a distinguished physician-scientist with both big pharma and biotech experience. Thus, when someone like him questions the wisdom of pharma investing in early research, it deserves some soul searching.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes


comments powered by Disqus
Forbes
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES